| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 06/30/2004 | EP1432435A1 Enamel matrix protein compositions for modulating immune response |
| 06/30/2004 | EP1432430A2 Pre-mixes of glp-1 and basal insulin |
| 06/30/2004 | EP1432425A1 A method of reducing the "in vivo" cholesterol ester transfer protein mediated transfer of cholesteryl esters between high density lipoproteins (hdl) and low density lipoproteins (ldl) |
| 06/30/2004 | EP1432424A1 Heterocyclic substituted 2- (4-phenoxy) pyridine derivatives and related compounds as sodium channel blockers for the treatment of neuronal damage and neurodegenerative conditions |
| 06/30/2004 | EP1432423A2 Pharmaceutical combinations of pde-v inhibitors and other agents |
| 06/30/2004 | EP1432421A1 Quinoline derivatives as neuropeptide y antagonists |
| 06/30/2004 | EP1432419A1 Aryl substituted pyridinecarboxamides and their use as sodium channel blockers |
| 06/30/2004 | EP1432416A1 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 06/30/2004 | EP1432415A1 Substituted 2,5-diamidoindoles as ece inhibitors for the treatment of cardiovascular diseases |
| 06/30/2004 | EP1432411A1 Timed, sustained release multi-particulate dosage forms of propranolol |
| 06/30/2004 | EP1432407A1 Lisinopril compositions having large-particle dcpd |
| 06/30/2004 | EP1432402A2 Compositions for delivery of drug combinations |
| 06/30/2004 | EP1432310A2 Method to treat chronic heart failure and/or elevated cholesterol levels using 3,5-diiodothyropropionic acid and method to prepare same |
| 06/30/2004 | EP1385509A4 Method of treatment |
| 06/30/2004 | EP1149072B1 Sulfonamide hydroxamates |
| 06/30/2004 | EP1080081B1 Benzofuroxan derivatives and their use in treating angina pectoris |
| 06/30/2004 | EP1070049B1 Benzamide and sulfonamide substituted aminoguanidines and alkoxyguanidines as protease inhibitors |
| 06/30/2004 | EP1045693B1 Aminophenoxyacetic acid derivatives as neuroprotectants |
| 06/30/2004 | EP1019408B1 1,2,3,4-TETRAHYDRO-BENZOFURO[3,2-c]PYRIDINE DERIVATIVES |
| 06/30/2004 | EP1009743B1 Certain benzothiazine dioxide endothelin antagonists and processes for their preparation |
| 06/30/2004 | EP0971908B1 Il-8 receptor antagonists |
| 06/30/2004 | CN1509337A New polynucleotides and polypeptides of IFN alpha-17 gene |
| 06/30/2004 | CN1509333A Novel neurotrophic factors |
| 06/30/2004 | CN1509294A High density lipoprotein-reactive peptides |
| 06/30/2004 | CN1509288A The citrate salt of 5,8,14-triazatetracyclo (10.3.1.0.2,11.0.4,9)-hexadeca-2.(11),3,5,7,9-pentaene |
| 06/30/2004 | CN1509286A Metalloproteinase inhibitors |
| 06/30/2004 | CN1509276A Metalloproteinase inhibitors |
| 06/30/2004 | CN1509275A Metalloproteinase inhibitors |
| 06/30/2004 | CN1509274A Metallo proteinase inhibitors |
| 06/30/2004 | CN1509273A Metalloproteinase inhibitors |
| 06/30/2004 | CN1509272A Metalloproteinase inhibitors |
| 06/30/2004 | CN1509271A 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for treatment of pain anxiety or gastrointestinal disorders |
| 06/30/2004 | CN1509267A Thyroid hormone receptor atagonists for treating cardiac and metabolic disorders II |
| 06/30/2004 | CN1509196A 4(2-butylamino)-2,7-dimethyl-8-(2-methyl(-6-methoxyp-3-yl)pyrazolo-[1,5-A]-1,3,5-triazine as corticotropin releasing factor receptor |
| 06/30/2004 | CN1509178A Pharmaceutical composition comprising lysophosphatidic acid |
| 06/30/2004 | CN1509174A Tartrate salt of 5,8,14-triazatetracyclo [10,3,1,02,11.04,9]-hexzdeca-2(11),3,5,7,9-pentaene |
| 06/30/2004 | CN1509173A Carboxylic and substituted oxazole derivatives for use as PPAR-& and PPAR-r activators in the treatment of diabetes |
| 06/30/2004 | CN1508542A Ginkgo leaf composition, and preparing method and use thereof |
| 06/30/2004 | CN1508146A Anti-tumour ginseng saponin |
| 06/30/2004 | CN1508137A 2-phenyl-substituted imidazo-triazone used as phosphodiesterase inhibitor |
| 06/30/2004 | CN1507918A Transdermal promotor glycerin triacetate |
| 06/30/2004 | CN1507910A Medicinal composition for treating apoplexia, and preparing method and use thereof |
| 06/30/2004 | CN1507909A Freeze-dried powder injection for treating carido-cerebrovascular disease and preparing method thereof |
| 06/30/2004 | CN1507908A Medicinal composition for treating coronary heart disease and hypertension and preparing method thereof |
| 06/30/2004 | CN1507907A Medicinal injection for treating cardio-cerebrovascular disease and preparing method thereof |
| 06/30/2004 | CN1507906A Medicine for treating cardio-cerebro vascular disease and preparing method thereof |
| 06/30/2004 | CN1507903A Health-care product for antilipemic and preventing cardio-cerebrovascular disease |
| 06/30/2004 | CN1507891A Series medicament of zanthoxylum bungeanum seed kernel oil and pseudo-ginseng total saponin and preparing process thereof |
| 06/30/2004 | CN1507890A Series medicament of zanthoxylum bungeanum seed kernel oil and ligusticum wallichiil alkaloid and preparing process thereof |
| 06/30/2004 | CN1507889A Series medicament of zanthoxylum bungeanum seed kernel oil and red-rooted salvia root alcohol extract and preparing process thereof |
| 06/30/2004 | CN1507859A Pravastatin preparation formula |
| 06/30/2004 | CN1507856A Medicinal plaster for depressing hyper tension |
| 06/30/2004 | CN1155611C Endothelin antagon |
| 06/30/2004 | CN1155608C Propargyl phenyl ether A2A receptor agonists |
| 06/30/2004 | CN1155602C Thineopyranecarboxyamide derivatives |
| 06/30/2004 | CN1155600C 2,3-diaryl-pyrazolo[1,5-B] pyridazines derivatives, their prepn. and use as cyclooxygenase 2(cox-2) inhibitors |
| 06/30/2004 | CN1155594C Polymorphic salt as medicine for migraine |
| 06/30/2004 | CN1155409C Medical compsns. for preventing and treating arteriosclerotic desease |
| 06/30/2004 | CN1155375C Linolic acid and linolenic acid capsule and its making process |
| 06/29/2004 | US6756480 Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein |
| 06/29/2004 | US6756409 For therapy and prophylaxis of pain and/or neurodegenerative disorders |
| 06/29/2004 | US6756401 Drug mixtures comprising estrogen agonists or antagonists and anticholesterol statins, administered to promote bone formation, prevent bone disorders and/or as anticholesterol agents |
| 06/29/2004 | US6756393 Amides and ureas n-substituted with piperidine or nortropane; serotonin inverse agonists or antagonists; antipsychotic |
| 06/29/2004 | US6756389 Pharmaceutically active compounds and methods of use |
| 06/29/2004 | US6756388 Having piperidinyl and phenolic functionality; bone loss; breast or prostate cancer |
| 06/29/2004 | US6756383 Such as 3-(2-(methoxycarbonyl)acetylamino)pyridine-4-carboxylic acid for treatment of diseases characterized by activity of vascular endothelial growth factor receptor tyrosine kinases; enzyme inhibitors |
| 06/29/2004 | US6756381 A purified antitumor agent is crystallized from acetone or dichloromethane |
| 06/29/2004 | US6756380 5-phenyl-pyrimidine derivatives |
| 06/29/2004 | US6756376 Preventing fatty acid release |
| 06/29/2004 | US6756375 Estrogen receptor modulation; hormone replacement therapy |
| 06/29/2004 | US6756372 For therapy of autoimmune diseases, alzheimer's disease, atherosclerosis, osteoporosis, rheumatoid arthritis, systemic lupus erythematosus, crohn's disease, ulcerative colitis, multiple sclerosis, guillain-barre syndrome, psoriasis |
| 06/29/2004 | US6756371 Morpholino or thiomorpholino derivatives; respiratory system disorders |
| 06/29/2004 | US6756065 Anti-oxidant preparation based on plant extracts for the treatment of circulation and adiposity problems |
| 06/29/2004 | US6756053 Establishing a drug depot in tissues under the user's skin surface by applying a transdermal drug delivery system on a user's skin; allowing transdermal drug delivery system to be applied on skin area without heating; placing heating source |
| 06/29/2004 | US6756047 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
| 06/29/2004 | US6756033 Method for delivering benzindene prostaglandins by inhalation |
| 06/29/2004 | US6756031 One or more of: polyacrylonitrile, polyvinylacetate, cellulose acetate butyrate, nitrocellulose and polycarbonateurethane copolymers and maleic acid-styrene copolymers; a contrast agent, and a biocompatible solvent |
| 06/29/2004 | US6755856 Methods and apparatus for stenting comprising enhanced embolic protection, coupled with improved protection against restenosis and thrombus formation |
| 06/29/2004 | CA2296726C Combination therapy |
| 06/29/2004 | CA2207404C Imidazole derivatives as protein kinase inhibitors in particular egf-r tyrosine kinase |
| 06/29/2004 | CA2205384C Dihydropyrimidines and uses thereof |
| 06/29/2004 | CA2171827C Use of thiazolidinediones to prevent or delay onset of niddm |
| 06/24/2004 | WO2004052880A1 Pyridine derivatives as jnk inhibitors and their use |
| 06/24/2004 | WO2004052871A1 Benzomorpholine derivatives |
| 06/24/2004 | WO2004052863A1 Anti-inflammatory agent |
| 06/24/2004 | WO2004052862A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof |
| 06/24/2004 | WO2004052847A2 Tricyclic steroid hormone nuclear receptor modulators |
| 06/24/2004 | WO2004052841A1 Carbidopa prodrugs and uses thereof |
| 06/24/2004 | WO2004052839A1 Isophtalic acid derivatives |
| 06/24/2004 | WO2004052389A2 Nogo, caspr, f3 nb-3 useful in the treatment of injury and disease to the central nervous system |
| 06/24/2004 | WO2004052383A1 An composition containing triterpenoid saponins extracted from bamboo, and the preparation method and use thereof |
| 06/24/2004 | WO2004052366A1 2-aminocarbonyl-quinoline compounds as platelet adenosine diphosphate receptor antagonists |
| 06/24/2004 | WO2004052365A2 Inhibition of inflamation using alpha 7 receptor-binding cholinergic agonists |
| 06/24/2004 | WO2004052361A1 Microtubule stabilisers for treating stenosis in stents |
| 06/24/2004 | WO2004052357A1 Labeled macrophage scavenger receptor antagonists for imaging cardiovascular diseases |
| 06/24/2004 | WO2004043982A3 Novel ampiphilic derivatives of alpha-c-phenyl n-tert-butyl nitrone |
| 06/24/2004 | WO2004030607A3 Peptide-based passive immunization therapy for treatment of atherosclerosis |
| 06/24/2004 | WO2004024883A3 PAKs AS MODIFIERS OF THE CHK PATHWAY AND METHODS OF USE |
| 06/24/2004 | WO2004022716A3 Recombinatant mutants of rhabdovirus and methods of use thereof |
| 06/24/2004 | WO2004018044A8 N-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-'1,3,4-oxadiazol-2-yl!phenyl)pyridine-3 sulphonamide as an anticancer agent |